| Financial Year |
March 31 2023 |
| Monetary Funds |
300,651,268.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,689,900.00 |
| Accounts Receivable |
179,090,133.08 |
| Advances to Suppliers |
14,705,892.80 |
| Other Receivables |
4,431,547.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
147,068,811.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,020,989.57 |
| Total Current Assets |
668,409,134.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,806,725.01 |
| Investment Properties |
-- |
| Fixed Assetes |
69,958,520.08 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,789,293.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,724,692.29 |
| Deferred Income Tax Assets |
16,148,344.52 |
| Other Non-Current Assets |
12,106,784.48 |
| Sub-Total of Non-Current Assets |
190,361,701.68 |
| Total Assets |
858,770,836.53 |
| Short-Term Loans |
55,848,098.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,425,845.00 |
| Accounts Payable |
102,404,940.78 |
| Accounts Received In Advance |
1,104,372.55 |
| Employee Compensation Payable |
5,567,622.78 |
| Taxes Payable |
2,071,501.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,066,276.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,134,068.62 |
| Other Current Liabilities |
478,685.66 |
| Sub-Total of Current Liabilities |
182,236,031.66 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,651,636.02 |
| Deferred Income Tax Liabilities |
1,000,655.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,945,026.85 |
| Total Liabilities |
208,181,058.51 |
| Paid-In Capital(Or Share Stock) |
197,040,865.00 |
| Capital Surplus |
529,605,330.63 |
| Surplus Reserve |
24,509,235.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-117,942,895.19 |
| Minority Stockholder's Interest |
20,877,242.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
629,712,535.94 |
| Owner's Equity（Stockholder's Equity） |
650,589,778.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
858,770,836.53 |
